KaliVir Immunotherapeutics

Funding reported, Series A, last update 2 weeks ago

Pharma biotech

Everything we hold on KaliVir Immunotherapeutics, newest first. Every line links to the filing or report it came from.

This profile is thin because we hold one source document on KaliVir Immunotherapeutics so far, not because nothing else has happened there. We only publish what we have read on a primary source and can link to. So a profile fills up as filings and reports come in, and we never seed it from an estimate. We keep profiles at this stage out of our sitemap and mark them noindex until they carry enough to be worth a search result of their own.

1. 2026-08-19
   Headcount Not Stated Growing and expanding

   KaliVir Immunotherapeutics Announces Closing of $14 Million Series A Extension Financing

   KaliVir Immunotherapeutics has $14M of new capital in a Series A extension. The announcement does not disclose hiring plans; watch its careers page for pharma and biotech roles.

   $14M raised · News Report · BioSpace · archived copy

The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker